Talking it out: psychotherapy boosts brain power in schizophrenia

NCT ID NCT07477301

First seen Mar 20, 2026 · Last updated May 14, 2026 · Updated 6 times

Summary

This study tested whether adding structured supportive psychotherapy to the antipsychotic risperidone helps improve cognitive function and reduce inflammation in people with schizophrenia. Forty-six men with early-stage schizophrenia took part. Half received risperidone plus 12 sessions of talk therapy over 6 weeks, while the other half received risperidone alone. The study measured changes in thinking skills and a blood marker of inflammation (hs-CRP).

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Dadi Psychiatric Hospital

    Makassar, South Sulawesi, 90245, Indonesia

Conditions

Explore the condition pages connected to this study.